Kestra Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Kestra Medical Technologies
KMTS Stock   23.00  0.15  0.66%   
Kestra Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Kestra Medical's valuation are provided below:
Gross Profit
34.5 M
Profit Margin
(1.78)
Market Capitalization
1.3 B
Enterprise Value Revenue
16.1952
Revenue
74.3 M
There are over one hundred nineteen available fundamental ratios for Kestra Medical, which can be analyzed over time and compared to other ratios. All traders should check Kestra Medical's last-minute fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to gain to about 1.2 B in 2026

Kestra Medical Total Revenue

72.23 Million

Check Kestra Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kestra Medical's main balance sheet or income statement drivers, such as Tax Provision of 81.4 K, Depreciation And Amortization of 5.6 M or Interest Expense of 4.6 M, as well as many indicators such as Price To Sales Ratio of 21.77, Dividend Yield of 0.0013 or PTB Ratio of 6.34. Kestra financial statements analysis is a perfect complement when working with Kestra Medical Valuation or Volatility modules.
  
Build AI portfolio with Kestra Stock
Check out the analysis of Kestra Medical Correlation against competitors.

Kestra Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets357.1 M340.1 M72.1 M
Slightly volatile
Short and Long Term Debt Total33.4 M51 M16.4 M
Slightly volatile
Other Current Liabilities8 M15.7 M4.9 M
Slightly volatile
Total Current Liabilities26 M43.7 M15.3 M
Slightly volatile
Property Plant And Equipment Net44.6 M42.4 M11.8 M
Slightly volatile
Accounts Payable28.9 M27.6 M8 M
Slightly volatile
Cash286.9 M273.2 M54 M
Slightly volatile
Non Current Assets Total48.8 M46.5 M13.4 M
Slightly volatile
Non Currrent Assets Other2.5 M4 M1.6 M
Slightly volatile
Cash And Short Term Investments286.9 M273.2 M54 M
Slightly volatile
Common Stock Shares Outstanding39.6 M44.6 M48.7 M
Slightly volatile
Liabilities And Stockholders Equity357.1 M340.1 M72.1 M
Slightly volatile
Capital Lease Obligations2.3 M3.7 M1.3 M
Slightly volatile
Other Stockholder Equity814.2 M775.5 M260 M
Slightly volatile
Total Liabilities117.6 M103.9 M55.8 M
Slightly volatile
Property Plant And Equipment Gross73.5 M70 M19.1 M
Slightly volatile
Total Current Assets308.3 M293.6 M58.6 M
Slightly volatile
Capital Stock62 M59.1 M10.1 M
Slightly volatile
Short Term Debt408.6 K430.1 K3 M
Pretty Stable
Common Stock62 M59.1 M10.1 M
Slightly volatile
Long Term Debt33.3 M47.3 M24.8 M
Slightly volatile
Non Current Liabilities Other127.8 K126 K268 K
Slightly volatile
Net Receivables9.8 M9.3 M3.3 M
Slightly volatile
Inventory4.4 M7.6 M2.9 M
Slightly volatile
Short and Long Term Debt16.4 M18.4 M20.1 M
Slightly volatile

Kestra Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Tax Provision81.4 K121.5 K121.1 K
Slightly volatile
Depreciation And Amortization5.6 M9.2 M2.9 M
Slightly volatile
Selling General Administrative138.8 M132.2 M31.3 M
Slightly volatile
Selling And Marketing Expenses26.4 M46.8 M17.9 M
Slightly volatile
Other Operating Expenses200.7 M191.1 M69 M
Slightly volatile
Research Development14.2 M14.1 M19.9 M
Slightly volatile
Total Operating Expenses76.5 M150.2 M53.4 M
Slightly volatile
Reconciled Depreciation5.6 M9.2 M2.9 M
Slightly volatile
Income Tax Expense81.4 K121.5 K121.1 K
Slightly volatile
Cost Of Revenue29.8 M40.9 M21.9 M
Slightly volatile

Kestra Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow9 M9.9 M7.3 M
Slightly volatile
Other Cashflows From Financing Activities77.1 M133.5 M55.1 M
Slightly volatile
Depreciation5.6 M9.2 M2.9 M
Slightly volatile
Other Non Cash Items12.2 M11.6 M3.6 M
Slightly volatile
Dividends Paid2 M1.9 M571.3 K
Slightly volatile
Capital Expenditures28.5 M27.1 M7.4 M
Slightly volatile
Total Cash From Financing Activities398.8 M379.8 M101.8 M
Slightly volatile
End Period Cash Flow287.3 M273.6 M54.4 M
Slightly volatile
Other Cashflows From Investing Activities209 K325.4 K99.7 K
Slightly volatile
Issuance Of Capital Stock385.4 M367.1 M145.5 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio21.7722.91115
Slightly volatile
Dividend Yield0.00130.00125.0E-4
Slightly volatile
Days Sales Outstanding64.7656.7188.8852
Slightly volatile
Stock Based Compensation To Revenue0.380.370.1923
Slightly volatile
Capex To Depreciation1.362.661.1815
Slightly volatile
EV To Sales18.2419.2116
Slightly volatile
Inventory Turnover8.226.238.2755
Slightly volatile
Days Of Inventory On Hand40.8860.6344.7691
Slightly volatile
Payables Turnover2.061.712.6454
Slightly volatile
Sales General And Administrative To Revenue1.961.212.224
Slightly volatile
Research And Ddevelopement To Revenue0.290.31.662
Slightly volatile
Capex To Revenue0.430.451.651
Slightly volatile
Cash Per Share4.534.320.945
Slightly volatile
Days Payables Outstanding183221151
Slightly volatile
Income Quality0.920.780.9388
Slightly volatile
Current Ratio6.356.052.3471
Slightly volatile
Receivables Turnover6.656.664.7986
Slightly volatile
Capex Per Share0.450.430.1345
Slightly volatile
Revenue Per Share1.141.090.353
Slightly volatile
Interest Debt Per Share0.560.950.3519
Slightly volatile
Debt To Assets0.130.14980.2788
Slightly volatile
Operating Cycle121134136
Slightly volatile
Days Of Payables Outstanding183221151
Slightly volatile
Ebt Per Ebit0.850.961.0285
Slightly volatile
Quick Ratio6.195.92.3061
Slightly volatile
Net Income Per E B T1.11.151.0181
Slightly volatile
Cash Ratio5.915.632.1688
Slightly volatile
Days Of Inventory Outstanding40.8860.6344.7691
Slightly volatile
Days Of Sales Outstanding64.7656.7188.8852
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.911.171.0641
Slightly volatile
Fixed Asset Turnover0.821.460.636
Slightly volatile
Debt Ratio0.130.14980.2788
Slightly volatile
Price Sales Ratio21.7722.91115
Slightly volatile
Asset Turnover0.260.180.2243
Slightly volatile

Kestra Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap883 M1.1 B1.1 B
Pretty Stable
Enterprise Value1.2 B1.1 B1.1 B
Slightly volatile

Kestra Fundamental Market Drivers

About Kestra Medical Financial Statements

Kestra Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Kestra Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Kestra Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Kestra Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue68.8 M72.2 M
Cost Of Revenue40.9 M29.8 M
Stock Based Compensation To Revenue 0.37  0.38 
Sales General And Administrative To Revenue 1.21  1.96 
Research And Ddevelopement To Revenue 0.30  0.29 
Capex To Revenue 0.45  0.43 
Revenue Per Share 1.09  1.14 
Ebit Per Revenue(1.60)(1.68)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Kestra Stock Analysis

When running Kestra Medical's price analysis, check to measure Kestra Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kestra Medical is operating at the current time. Most of Kestra Medical's value examination focuses on studying past and present price action to predict the probability of Kestra Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kestra Medical's price. Additionally, you may evaluate how the addition of Kestra Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY